Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer

<div>Molecular docking. (a–c) Molecular docking of luteolin and AKT1, EGFR, and TP53. (d–f) Molecular docking of quercetin and AKT1, EGFR, and TP53.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer 

Figure 5 | Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer 